Free. Unsubscribe any time.
INSMED Inc (INSM)
INSMED Inc filed 78 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 8 reporting owners, covering 284 transactions and 2,025,640 shares. None carries the SEC's AFF10B5ONE flag; all 78 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-08-07, came 14 days after the one before it (2026-07-24) and reports 6 transactions against 6 in the filing before it.
- The sales it reports total 27,173 shares, 16,473 more than the 10,700 in the filing before it.
- Its 78 plan statements rank 1st of the 3 companies the register carries in Virginia, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 1 has more plan statements on file than it and 9 have fewer.
- Its 78 filings on file run from 2025-01-03 to 2026-08-07, and state 11 plan adoption dates, from 2024-06-07 to 2025-12-03.
Trades in INSMED Inc 284
- Lewis William — 2025-01-02 · S · 18,750 shares
- Lewis William — 2025-01-02 · S · 6,830 shares
- Adsett Roger — 2025-01-07 · S · 2,444 shares
- Flammer Martina M.D. — 2025-01-07 · S · 3,344 shares
- Schaeffer Orlov S Nicole — 2025-01-07 · S · 2,596 shares
- Wise John Drayton — 2025-01-07 · S · 10,000 shares
- Wise John Drayton — 2025-01-07 · S · 2,908 shares
- Adsett Roger — 2025-01-08 · S · 1,882 shares
- Flammer Martina M.D. — 2025-01-08 · S · 1,702 shares
- Schaeffer Orlov S Nicole — 2025-01-08 · S · 1,209 shares
- Wise John Drayton — 2025-01-08 · S · 392 shares
- Adsett Roger — 2025-01-10 · S · 1,298 shares
Adoption dates in INSMED Inc 11
- 2024-06-07 — stated in 2 filings
- 2024-08-15 — stated in 1 filing
- 2024-09-12 — stated in 6 filings
- 2025-02-27 — stated in 18 filings
- 2025-03-04 — stated in 2 filings
- 2025-03-05 — stated in 4 filings
- 2025-06-13 — stated in 1 filing
- 2025-08-29 — stated in 1 filing
- 2025-09-04 — stated in 16 filings
- 2025-11-07 — stated in 4 filings
- 2025-12-03 — stated in 1 filing
Results prints in INSMED Inc 7
- 2025-02-20
- 2025-05-08
- 2025-08-07
- 2025-10-30
- 2026-02-19
- 2026-05-07
- 2026-08-06
Trades before a print in INSMED Inc 25
- 0 days before the 2026-02-19 print — 2026-02-19 · S · Lewis William · 1,988 shares
- 0 days before the 2026-02-19 print — 2026-02-19 · S · Lewis William · 1,891 shares
- 0 days before the 2026-02-19 print — 2026-02-19 · S · Lewis William · 3,413 shares
- 0 days before the 2026-02-19 print — 2026-02-19 · S · Lewis William · 2,377 shares
- 0 days before the 2026-02-19 print — 2026-02-19 · S · Lewis William · 1,030 shares
- 0 days before the 2026-08-06 print — 2026-08-06 · S · Flammer Martina M.D. · 8,895 shares
- 0 days before the 2026-08-06 print — 2026-08-06 · S · Flammer Martina M.D. · 18,278 shares
- 2 days before the 2025-02-20 print — 2025-02-18 · S · Bonstein Sara · 17,622 shares
- 2 days before the 2025-02-20 print — 2025-02-18 · S · Bonstein Sara · 700 shares
- 2 days before the 2025-02-20 print — 2025-02-18 · S · Lewis William · 1,253 shares
- 2 days before the 2025-02-20 print — 2025-02-18 · S · Lewis William · 16,743 shares
- 2 days before the 2025-02-20 print — 2025-02-18 · S · Lewis William · 754 shares
Interval to INSMED Inc’s next reported results date
How the interval and sources are counted →
- 25within 5 days
- 38within 10 days
- 0shortest, days
- 0no later print
- Adsett Roger 2025-02-10 · S · 10 days before the 2025-02-20 print · Chief Operating Officer
- Adsett Roger 2025-02-10 · S · 10 days before the 2025-02-20 print · Chief Operating Officer
- Adsett Roger 2025-02-10 · S · 10 days before the 2025-02-20 print · Chief Operating Officer
- Flammer Martina M.D. 2025-02-10 · S · 10 days before the 2025-02-20 print · Chief Medical Officer
- Flammer Martina M.D. 2025-02-10 · S · 10 days before the 2025-02-20 print · Chief Medical Officer
- Flammer Martina M.D. 2025-02-10 · S · 10 days before the 2025-02-20 print · Chief Medical Officer
- Bonstein Sara 2025-02-11 · S · 9 days before the 2025-02-20 print · Chief Financial Officer
- Bonstein Sara 2025-02-12 · S · 8 days before the 2025-02-20 print · Chief Financial Officer
- Bonstein Sara 2025-02-18 · S · 2 days before the 2025-02-20 print · Chief Financial Officer
- Bonstein Sara 2025-02-18 · S · 2 days before the 2025-02-20 print · Chief Financial Officer
- Lewis William 2025-02-18 · S · 2 days before the 2025-02-20 print · Chair and CEO
- Lewis William 2025-02-18 · S · 2 days before the 2025-02-20 print · Chair and CEO
- Lewis William 2025-02-18 · S · 2 days before the 2025-02-20 print · Chair and CEO
- Lewis William 2025-02-18 · S · 2 days before the 2025-02-20 print · Chair and CEO
- Lewis William 2025-02-18 · S · 2 days before the 2025-02-20 print · Chair and CEO
- Lewis William 2025-02-18 · S · 2 days before the 2025-02-20 print · Chair and CEO
- Lewis William 2025-05-01 · S · 7 days before the 2025-05-08 print · Chair and CEO
- Lewis William 2025-05-01 · S · 7 days before the 2025-05-08 print · Chair and CEO
- Flammer Martina M.D. 2025-08-04 · S · 3 days before the 2025-08-07 print · Chief Medical Officer
- Lewis William 2025-08-04 · S · 3 days before the 2025-08-07 print · Chair and CEO
Adoption dates INSMED Inc states
- 2024-06-07 in 2 filings
- 2024-08-15 in 1 filing
- 2024-09-12 in 6 filings
- 2025-02-27 in 18 filings
- 2025-03-04 in 2 filings
- 2025-03-05 in 4 filings
- 2025-06-13 in 1 filing
- 2025-08-29 in 1 filing
- 2025-09-04 in 16 filings
- 2025-11-07 in 4 filings
- 2025-12-03 in 1 filing
Filing text: “10b5-1 trading plan adopted by the Reporting Person on February 27, 2025”
Reported results dates on file
- 2025-02-20
- 2025-05-08
- 2025-08-07
- 2025-10-30
- 2026-02-19
- 2026-05-07
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.